These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18224255)

  • 1. In silico-aided prediction of biological properties of chemicals: oestrogen receptor-mediated effects.
    Roncaglioni A; Benfenati E
    Chem Soc Rev; 2008 Mar; 37(3):441-50. PubMed ID: 18224255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico prediction of harmful effects triggered by drugs and chemicals.
    Vedani A; Dobler M; Lill MA
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):398-407. PubMed ID: 16045954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The challenge of predicting drug toxicity in silico.
    Vedani A; Dobler M; Lill MA
    Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):195-208. PubMed ID: 16930291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico prediction of receptor-mediated environmental toxic phenomena-application to endocrine disruption.
    Lill MA; Dobler M; Vedani A
    SAR QSAR Environ Res; 2005; 16(1-2):149-69. PubMed ID: 15844448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico screening of estrogen-like chemicals based on different nonlinear classification models.
    Liu H; Papa E; Walker JD; Gramatica P
    J Mol Graph Model; 2007 Jul; 26(1):135-44. PubMed ID: 17293141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico tools to aid risk assessment of endocrine disrupting chemicals.
    Jacobs MN
    Toxicology; 2004 Dec; 205(1-2):43-53. PubMed ID: 15458789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSAR prediction of estrogen activity for a large set of diverse chemicals under the guidance of OECD principles.
    Liu H; Papa E; Gramatica P
    Chem Res Toxicol; 2006 Nov; 19(11):1540-8. PubMed ID: 17112243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico identification of anthropogenic chemicals as ligands of zebrafish sex hormone binding globulin.
    Thorsteinson N; Ban F; Santos-Filho O; Tabaei SM; Miguel-Queralt S; Underhill C; Cherkasov A; Hammond GL
    Toxicol Appl Pharmacol; 2009 Jan; 234(1):47-57. PubMed ID: 18725242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico toxicology for the pharmaceutical sciences.
    Valerio LG
    Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
    Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
    Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance-tailored testing strategies in toxicology: an in silico methodology based on QSAR modeling of toxicological thresholds and Monte Carlo simulations of toxicological testing.
    Péry AR; Desmots S; Mombelli E
    Regul Toxicol Pharmacol; 2010 Feb; 56(1):82-92. PubMed ID: 19766156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of binary QSAR models derived from LUDI and MOE scoring functions for structure based virtual screening.
    Prathipati P; Saxena AK
    J Chem Inf Model; 2006; 46(1):39-51. PubMed ID: 16426038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QSAR classification of estrogen receptor binders and pre-screening of potential pleiotropic EDCs.
    Li J; Gramatica P
    SAR QSAR Environ Res; 2010 Oct; 21(7-8):657-69. PubMed ID: 21120754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virtual test kits for predicting harmful effects triggered by drugs and chemicals mediated by specific proteins.
    Vedani A; Dobler M; Lill MA
    ALTEX; 2005; 22(3):123-34. PubMed ID: 16186988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular determinants of hormone mimicry: halogenated aromatic hydrocarbon environmental agents.
    McKinney JD; Waller CL
    J Toxicol Environ Health B Crit Rev; 1998; 1(1):27-58. PubMed ID: 9487092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alignment-free prediction of a drug-target complex network based on parameters of drug connectivity and protein sequence of receptors.
    Viña D; Uriarte E; Orallo F; González-Díaz H
    Mol Pharm; 2009; 6(3):825-35. PubMed ID: 19281186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binary classification models for endocrine disrupter effects mediated through the estrogen receptor.
    Roncaglioni A; Piclin N; Pintore M; Benfenati E
    SAR QSAR Environ Res; 2008; 19(7-8):697-733. PubMed ID: 19061085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationship study of a diverse set of estrogen receptor ligands (I) using MultiCASE expert system.
    Klopman G; Chakravarti SK
    Chemosphere; 2003 May; 51(6):445-59. PubMed ID: 12615096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining protein modeling and 6D-QSAR. Simulating the binding of structurally diverse ligands to the estrogen receptor.
    Vedani A; Dobler M; Lill MA
    J Med Chem; 2005 Jun; 48(11):3700-3. PubMed ID: 15916421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.